New York Files Charges Against Members of Sackler Family

New York Attorney General Letitia James has added members of the Sackler family to a lawsuit against their company, opioid manufacturer Purdue Pharma, alleging financial chicanery. On Thursday, James included eight members of the billionaire family as defendants, alleging they used a number of corporate entities to transfer money to themselves via private or offshore […]

OxyContin Outcry Forces Purdue’s Sackler Family to Suspend Arts Donations

The family that controls Purdue Pharma is halting new donations from its trust after a series of rejected donations from high-profile arts institutions last week. A lawsuit against Purdue naming eight Sackler family members charges the company with aggressively marketing OxyContin despite being aware of its addictive qualities, contributing to the U.S. opioid epidemic. The […]

Second British Art Gallery Pledges to Reject Donations From Purdue Pharma’s Sackler Family

A group of British art galleries has become the second art institution to refuse donations from the Sackler family this week, citing the family’s connection to the prescription drug OxyContin and its role in the U.S. opioid epidemic. The Tate art galleries–which includes Tate Modern and Tate Britain in London, Tate St Ives, and Tate […]

National Portrait Gallery Rejects Donation From Purdue Pharma’s Sackler Family

A British art gallery has decided it won’t take 1 million pound ($1.3 million) pledge from a charitable organization run by Purdue Pharma’s Sackler family. In a statement on Wednesday, the National Portrait Gallery said that “recent reporting of allegations made against Sackler family members may cause this new donation to deflect the National Portrait […]

Purdue Pharma Reportedly Knew Doctors Underestimated OxyContin’s Strength

Purdue Pharma knew that doctors thought the painkiller OxyContin, which helped contribute to the current opioid crisis, was weaker than morphine when it was really twice as strong, ProPublica and STAT jointly reported. But the pharmaceutical company didn’t correct the misunderstanding because it was boosting use and sales of the product, according to email exchanges […]